C4 Therapeutics, Inc.(CCCC)Earnings Date, History & Expected Move
Next report date, beat rate and options-implied move
CCCC is scheduled to report on Nov 4, 2026, usually before the market opens. Analysts expect EPS of -$0.20.
EPS: Actual vs Estimate
Reported EPS against the consensus estimate, last 12 quarters.
Green beat or met, red missed, amber sources differ.
Stock Reaction After Earnings
Close-to-close move in the first session that reflected each report.
Dashed lines mark the average actual move (±8.1%).
Did the stock rise after good news?
The next-day move after each of its last 6 EPS beats and 4 misses.
In plain words: it beat expectations 6 times, but the stock still fell 1 of those 6 times.
- Aug '26Beat▲ +6.9%
- Feb '26Beat▲ +0.4%
- Aug '25Beat▲ +31.6%
- May '25Beat▲ +6.4%
- Feb '25Missed▼ -1.9%
- Oct '24Missed▼ -3.6%
- Aug '24Missed▼ -0.3%
- May '24Missed▼ -5.0%
- Feb '24Beat▲ +21.4%
- Nov '23Beat▼ -11.4%
Clear beats and misses with a known reaction only. What counts as a beat
Why did CCCC fall after beating earnings?
1 of CCCC's last 10 reactions went against the EPS result. What stands out in each:
CCCC beat EPS estimates in 6 quarters, and the stock still closed lower the next day 1 time.
- Nov 1, 2023EPS beat +16.9%stock -11.4% next day
- It had risen 5.7% in the final week before the report, so good news may already have been priced in.
- It opened 8.7% higher, but sellers took over and it closed -11.4%.
Patterns in estimates and prices, not confirmed causes: how we read them.
Was CCCC's earnings move already priced in?
CCCC's move in the month before each of its last 11 reports, against what it did after.
How the run-up is measured (a move of 5% or more counts as large).
Before vs after each report
Grey: the month before each of the last 11 reports. Green or red: the day after.
Past reports only. How the run-up is measured
Does CCCC hold its opening gap after earnings?
CCCC's opening move after each report and where it closed that day.
In 7 reports CCCC opened at least 1% away from the previous close. It gave back half or more of that gap by the close 4 of 7 times (57%), and fully reversed 3 times.
- Aug 11, 2026HeldOpened +6.1%, closed +6.9%
- Feb 26, 2026FadedOpened +5.8%, closed +0.4%
- Aug 7, 2025HeldOpened +2.0%, closed +31.6%
- May 7, 2025HeldOpened +10.6%, closed +6.4%
- Oct 31, 2024ReversedOpened +2.7%, closed -3.6%
- Aug 1, 2024ReversedOpened +2.8%, closed -0.3%
- Nov 1, 2023ReversedOpened +8.7%, closed -11.4%
What the history says
- CCCC has beaten EPS estimates in 5 straight quarters (quarters where our data sources disagree are skipped).
CCCC earnings history
Last 12 reported quarters with the stock's reaction.
Swipe sideways to see every column →
| Report date | Time | EPS est. | EPS actual | Surprise | 1-day move | 3-day move |
|---|---|---|---|---|---|---|
| Aug 11, 2026 | Before open | -$0.23 | -$0.18 | +21.7% | +6.91% | +12.71% |
| May 12, 2026 | Before open | -$0.26 | -$0.20 | +23.1% | — | — |
| Feb 26, 2026 | Before open | -$0.39 | -$0.18 | +53.8% | +0.36% | +14.44% |
| Nov 6, 2025 | Before open | -$0.39 | -$0.30 | sources differ | +0.42% | -1.27% |
| Aug 7, 2025 | Before open | -$0.38 | -$0.37 | +2.6% | +31.63% | +23.47% |
| May 7, 2025 | Before open | -$0.43 | -$0.37 | +14.0% | +6.38% | +4.26% |
| Feb 27, 2025 | Before open | -$0.45 | -$0.49 | -8.9% | -1.89% | -9.43% |
| Oct 31, 2024 | Before open | -$0.33 | -$0.35 | -6.1% | -3.62% | +16.64% |
| Aug 1, 2024 | Before open | -$0.18 | -$0.26 | -44.4% | -0.30% | -12.16% |
| May 8, 2024 | Before open | -$0.26 | -$0.38 | -46.2% | -5.01% | -9.28% |
| Feb 22, 2024 | Before open | -$0.69 | -$0.68 | +1.4% | +21.38% | +31.17% |
| Nov 1, 2023 | Before open | -$0.65 | -$0.54 | +16.9% | -11.41% | +4.70% |
Consensus for the next report: EPS -$0.20, revenue $9.00M.
CCCC Earnings FAQ
Answers computed from C4 Therapeutics, Inc.'s reported history
CCCC is scheduled to report on Nov 4, 2026, usually before the market opens. Analysts expect EPS of -$0.20.
Over the last 11 quarters with a usable EPS surprise, CCCC beat the consensus estimate 7 times (64%), missed 4 and landed in line 0. It has beaten estimates in each of the last 5 counted quarters. 1 quarter where our data sources disagree on beat versus miss are shown but not counted.
Across its last 11 quarters with a measured reaction, CCCC moved an average of ±8.1% in the first session after reporting. It closed higher 55% of the time; the largest gain was 31.6% and the largest drop -11.4%.
CCCC fell in the first session after 1 of its last 6 EPS beats (17%). A beat that was already priced in, or weaker guidance, can send a stock lower.
Across its last 11 quarters with price data, CCCC moved an average of +5.2% in the 20 trading sessions before reporting and was higher in 55% of them. After a run-up of 3% or more (5 quarters), it fell the next day 20% of the time, averaging +5.6%. After a drop of 3% or more (4 quarters), it rose the next day 25% of the time, averaging -2.8%. This describes past reports; it is not a forecast.
In 7 reports CCCC opened at least 1% away from the previous close. It gave back half or more of that gap by the close 4 of 7 times (57%), and fully reversed 3 times. A fade means the opening move was partly undone during the first session.
How we calculate these numbers · CCCC: 12 reported quarters, latest Aug 11, 2026. Information only, not investment advice.
Looking for more on CCCC?
Price charts, forecast, fundamentals and risk pages for CCCC are not on Tickzen yet. You can run a full stock analysis now.
Run the CCCC Stock AnalyzerLatest TickZen Insights
HSBC Q3 2026 Earnings Preview: Is the $46bn NII Guide Too Low?By Vishal Jadaun
Coca-Cola (KO) Q3 2026 Earnings Preview: Can Growth Justify Its Valuation?By Vishal Jadaun
Welltower Q3 2026 Earnings Preview: Can 20% Senior Housing Growth Last?By Vishal Jadaun